New leadership at Seattle-area companies including Starbucks, Avanade, Tune Therapeutics, Umoja Biopharma, Siteimprove and ...
Leading epigenome company Tune Therapeutics is proud to announce that veteran drug-development executive John McHutchison AO, ...
John McHutchison started Monday as CEO and chairman of Tune Therapeutics, after sitting on the company’s board for two years.
Launched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced a major milestone Sunday — raising $175 million in a Series B funding round to support its ...